Joint Pain Warning for Diabetes Meds
The U.S. Food and Drug Administration (FDA) is warning that the type 2 diabetes medicines sitagliptin, saxagliptin, linagliptin, and alogliptin may cause joint pain that can be severe and disabling.
Trends in Treating Diabetes
Diabetes is a big problem in the US — and thus, it is a big focus of doctors, researchers and pharmaceutical companies alike. New medications and developments alter how diabetes is treated.
Diabetes Rx May Keep Arthritis at Bay
Call it a gut reaction. A popular diabetes medication works by helping gastrointestinal hormones that encourage insulin production. The same medication may also help ward off autoimmune diseases.
FDA Investigating Risk of Pancreatitis in Type 2 Diabetes Meds
The US Food and Drug Administration (FDA) is evaluating unpublished new findings by a group of academic researchers that suggest an increased risk of pancreatitis, or inflammation of the pancreas, and pre-cancerous cellular changes called pancreatic duct metaplasia in patients with type 2 diabetes treated with a class of drugs called incretin mimetics.